• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP BR (ASSAY FOR CA 27.29); CA 27.29 ANTIGEN IMMUNOASSAY, PRODUCT CODE:

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP BR (ASSAY FOR CA 27.29); CA 27.29 ANTIGEN IMMUNOASSAY, PRODUCT CODE: Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/04/2014
Event Type  malfunction  
Event Description
A falsely low advia centaur xp br (assay for ca 27.29) dilution result was obtained by the customer on a patient sample and was considered discordant when compared to the over assay range neat result.An auto dilution of the patient sample was run and the result was over-dilution.The customer performed a manual dilution that was repeated with fresh multi-diluent 1 and the results were low.The neat sample was repeated and the br result was over the assay range upper limit.The customer performed serial dilution testing on the patient sample and observed low results.The patient sample was treated with heterophile blocking tubes (hbt) and nonspecific binding tubes and the br results were elevated.There is no known report of adverse health consequences due to the discordant lower advia centaur xp br (assay for ca 27.29) dilution results.
 
Manufacturer Narrative
The cause for the falsely low advia centaur xp br (assay for ca 27.29) dilution results when compared to the over assay range neat result and the elevated results when the patient sample was treated with heterophile blocking tubes (hbt) and nonspecific binding tubes may be attributed to an interfering substance.The customer's quality control results were within acceptable ranges and there were no other discordant br results reported by the customer for the advia centaur xp br (ca 27.29) assay at the time of the event.The limitations section of the instructions for use states the following: "warning do not use the advia centaur br assay as a screening test or for diagnosis.Normal levels of ca 27.29 do not always preclude the presence of disease.Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays.Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed.Additional information may be required.Note do not interpret levels of ca 27.29 as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed breast carcinoma frequently have levels of ca 27.29 within the range observed in healthy individuals.Additionally, elevated levels of ca 27.29 can be observed in patients with nonmalignant diseases.Measurements of ca 27.29 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation." the instrument is operating within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP BR (ASSAY FOR CA 27.29)
Type of Device
CA 27.29 ANTIGEN IMMUNOASSAY, PRODUCT CODE:
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
stephen perry
333 coney street
east walpole, MA 02032
5086604163
MDR Report Key3651712
MDR Text Key4199702
Report Number1219913-2014-00068
Device Sequence Number1
Product Code MOI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K982680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Medical Technologist
Remedial Action Inspection
Type of Report Initial
Report Date 02/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Medical Technologist
Device Expiration Date04/13/2013
Device Model NumberN/A
Device Catalogue Number03896216
Device Lot Number047207
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/04/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-